482 related articles for article (PubMed ID: 25572913)
41. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
[TBL] [Abstract][Full Text] [Related]
42. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
43. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
[TBL] [Abstract][Full Text] [Related]
44. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
45. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
46. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
47. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
48. Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data.
Thomas B; Stedman M; Davies L
Laryngoscope; 2014 Mar; 124(3):688-94. PubMed ID: 23945976
[TBL] [Abstract][Full Text] [Related]
49. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
Thomas WW; Fritsch VA; Lentsch EJ
Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
[TBL] [Abstract][Full Text] [Related]
50. Causes of death in long-term survivors of head and neck cancer.
Baxi SS; Pinheiro LC; Patil SM; Pfister DG; Oeffinger KC; Elkin EB
Cancer; 2014 May; 120(10):1507-13. PubMed ID: 24863390
[TBL] [Abstract][Full Text] [Related]
51. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma.
Asgari MM; Warton EM; Quesenberry CP; Koralek DO; Taylor M
J Am Acad Dermatol; 2014 Sep; 71(3):521-8. PubMed ID: 24856040
[TBL] [Abstract][Full Text] [Related]
52. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
53. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
54. Perioperative survival of elderly head and neck squamous cell carcinoma patients.
Stokes WA; Fuller C; Day TA; Gillespie MB
Laryngoscope; 2014 Oct; 124(10):2281-6. PubMed ID: 24470332
[TBL] [Abstract][Full Text] [Related]
55. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
[TBL] [Abstract][Full Text] [Related]
56. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
57. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
58. Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.
Hamada Y; Mizuno T; Tanaka K; Katsurahara M; Horiki N; Yamada R; Inoue H; Takei Y; Katayama N
Int J Clin Oncol; 2018 Apr; 23(2):243-248. PubMed ID: 29063984
[TBL] [Abstract][Full Text] [Related]
59. Site-specific familial risk and survival of familial and sporadic head and neck cancer.
Renkonen S; Lee M; Mäkitie A; Lindström LS; Czene K
Int J Cancer; 2017 Aug; 141(3):497-502. PubMed ID: 28439918
[TBL] [Abstract][Full Text] [Related]
60. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.
Atienza JA; Dasanu CA
Curr Med Res Opin; 2012 Dec; 28(12):1899-909. PubMed ID: 23121148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
